and targeted therapies
for the treatment of
Pascal Biosciences is dedicated to improving the lives of patients suffering from life-threatening diseases such as glioblastoma and other intractable cancers. We are developing novel cannabinoid-based small molecules and targeted antibodies, focusing on cancers for which there are no adequate therapies.
Pascal Biosciences Announces Private Placement and Potential Transaction with SŌRSE Technology for Cannabinoid Research Programs
March 10, 2020Read More
Pascal Biosciences and Y-Biologics Announce Research Collaboration for Development of a Bispecific Antibody for Leukemia
October 30, 2019Read More